Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phenoptin (Kuvan) in PKU with elevated Phe levels
NCT00104260Phase 2Completed
- Sponsor
- BioMarin Pharmaceutical
- Start
- Dec 2004
- Modality
- Allosteric Modulators, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 2 trial of sapropterin in phenylketonuria (PKU), sponsored by BioMarin Pharmaceutical. Started Dec 2004; status: completed.
02
Drugs
sapropterin
03
Conditions
phenylketonuria (PKU)
Beyond the preview
Go deeper on NCT00104260.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00104260.